222 related articles for article (PubMed ID: 10657544)
1. ABT-627, an endothelin ET(A) receptor-selective antagonist, attenuates tactile allodynia in a diabetic rat model of neuropathic pain.
Jarvis MF; Wessale JL; Zhu CZ; Lynch JJ; Dayton BD; Calzadilla SV; Padley RJ; Opgenorth TJ; Kowaluk EA
Eur J Pharmacol; 2000 Jan; 388(1):29-35. PubMed ID: 10657544
[TBL] [Abstract][Full Text] [Related]
2. Distinct actions of endothelin A-selective versus combined endothelin A/B receptor antagonists in early diabetic kidney disease.
Saleh MA; Pollock JS; Pollock DM
J Pharmacol Exp Ther; 2011 Jul; 338(1):263-70. PubMed ID: 21471190
[TBL] [Abstract][Full Text] [Related]
3. An adenosine kinase inhibitor attenuates tactile allodynia in a rat model of diabetic neuropathic pain.
Lynch JJ; Jarvis MF; Kowaluk EA
Eur J Pharmacol; 1999 Jan; 364(2-3):141-6. PubMed ID: 9932716
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of endothelin ETB receptor system aggravates neointimal hyperplasia after balloon injury of rat carotid artery.
Kitada K; Yui N; Matsumoto C; Mori T; Ohkita M; Matsumura Y
J Pharmacol Exp Ther; 2009 Dec; 331(3):998-1004. PubMed ID: 19737855
[TBL] [Abstract][Full Text] [Related]
5. Endothelin ETB receptor is involved in sex differences in the development of balloon injury-induced neointimal formation.
Kitada K; Yui N; Koyama M; Kimura K; Suzuki R; Tanaka R; Mori T; Ohkita M; Matsumura Y
J Pharmacol Exp Ther; 2011 Feb; 336(2):533-9. PubMed ID: 21075838
[TBL] [Abstract][Full Text] [Related]
6. ABT-702 (4-amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin- 3-yl)pyrido[2,3-d]pyrimidine), a novel orally effective adenosine kinase inhibitor with analgesic and anti-inflammatory properties. II. In vivo characterization in the rat.
Kowaluk EA; Mikusa J; Wismer CT; Zhu CZ; Schweitzer E; Lynch JJ; Lee CH; Jiang M; Bhagwat SS; Gomtsyan A; McKie J; Cox BF; Polakowski J; Reinhart G; Williams M; Jarvis MF
J Pharmacol Exp Ther; 2000 Dec; 295(3):1165-74. PubMed ID: 11082454
[TBL] [Abstract][Full Text] [Related]
7. Spinal pharmacology of tactile allodynia in diabetic rats.
Calcutt NA; Chaplan SR
Br J Pharmacol; 1997 Dec; 122(7):1478-82. PubMed ID: 9421298
[TBL] [Abstract][Full Text] [Related]
8. Antinociceptive effects of chronic administration of uncompetitive NMDA receptor antagonists in a rat model of diabetic neuropathic pain.
Chen SR; Samoriski G; Pan HL
Neuropharmacology; 2009 Aug; 57(2):121-6. PubMed ID: 19422840
[TBL] [Abstract][Full Text] [Related]
9. Evidence for vasoconstriction mediated by the endothelin-B receptor in domestic swine.
Burke SE; Nelson RA; Lubbers NL; Ford TT; Fu KI; Padley RJ; Wegner CD; Cox BF
J Cardiovasc Pharmacol; 2000 Jun; 35(6):838-44. PubMed ID: 10836715
[TBL] [Abstract][Full Text] [Related]
10. Melatonin reduces formalin-induced nociception and tactile allodynia in diabetic rats.
Arreola-Espino R; Urquiza-Marín H; Ambriz-Tututi M; Araiza-Saldaña CI; Caram-Salas NL; Rocha-González HI; Mixcoatl-Zecuatl T; Granados-Soto V
Eur J Pharmacol; 2007 Dec; 577(1-3):203-10. PubMed ID: 17920585
[TBL] [Abstract][Full Text] [Related]
11. Combined endothelin a blockade and chlorthalidone treatment in a rat model of metabolic syndrome.
Jin C; Jeon Y; Kleven DT; Pollock JS; White JJ; Pollock DM
J Pharmacol Exp Ther; 2014 Nov; 351(2):467-73. PubMed ID: 25189702
[TBL] [Abstract][Full Text] [Related]
12. Endothelin ET(B) receptor antagonist reduces mechanical allodynia in rats with trigeminal neuropathic pain.
Chichorro JG; Zampronio AR; Rae GA
Exp Biol Med (Maywood); 2006 Jun; 231(6):1136-40. PubMed ID: 16741064
[TBL] [Abstract][Full Text] [Related]
13. ABT-594, a novel cholinergic channel modulator, is efficacious in nerve ligation and diabetic neuropathy models of neuropathic pain.
Bannon AW; Decker MW; Kim DJ; Campbell JE; Arneric SP
Brain Res; 1998 Aug; 801(1-2):158-63. PubMed ID: 9729357
[TBL] [Abstract][Full Text] [Related]
14. Endothelin receptor A-specific stimulation of glomerular inflammation and injury in a streptozotocin-induced rat model of diabetes.
Saleh MA; Boesen EI; Pollock JS; Savin VJ; Pollock DM
Diabetologia; 2011 Apr; 54(4):979-88. PubMed ID: 21191784
[TBL] [Abstract][Full Text] [Related]
15. Role of endothelin ETB receptor in the pathogenesis of monocrotaline-induced pulmonary hypertension in rats.
Nishida M; Okada Y; Akiyoshi K; Eshiro K; Takoaka M; Gariepy CE; Yanagisawa M; Matsumura Y
Eur J Pharmacol; 2004 Aug; 496(1-3):159-65. PubMed ID: 15359489
[TBL] [Abstract][Full Text] [Related]
16. Endothelial endothelin B receptor-mediated prevention of cerebrovascular remodeling is attenuated in diabetes because of up-regulation of smooth muscle endothelin receptors.
Kelly-Cobbs AI; Harris AK; Elgebaly MM; Li W; Sachidanandam K; Portik-Dobos V; Johnson M; Ergul A
J Pharmacol Exp Ther; 2011 Apr; 337(1):9-15. PubMed ID: 21205912
[TBL] [Abstract][Full Text] [Related]
17. Renal and systemic effects of chronic blockade of ET(A) or ET(B) receptors in normal rats and animals with experimental heart failure.
Francis B; Winaver J; Karram T; Hoffman A; Abassi Z
J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S54-8. PubMed ID: 15838359
[TBL] [Abstract][Full Text] [Related]
18. 'Irreversible' endothelin-1 binding does not prohibit ABT-627 from reversing endothelin-1-induced effects.
Chiou WJ; Wessale JL; von Geldern T; Opgenorth TJ; Wu-Wong JR
J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S48-52. PubMed ID: 11078333
[TBL] [Abstract][Full Text] [Related]
19. Dynorphin A, kappa opioid receptors and the antinociceptive efficacy of asimadoline in streptozotocin-induced diabetic rats.
Jolivalt CG; Jiang Y; Freshwater JD; Bartoszyk GD; Calcutt NA
Diabetologia; 2006 Nov; 49(11):2775-85. PubMed ID: 16924480
[TBL] [Abstract][Full Text] [Related]
20. Pharmacology of A-216546: a highly selective antagonist for endothelin ET(A) receptor.
Wu-Wong JR; Dixon DB; Chiou WJ; Dayton BD; Novosad EI; Adler AL; Wessale JL; Calzadilla SV; Hernandez L; Marsh KC; Liu G; Szczepankiewicz B; von Geldern TW; Opgenorth TJ
Eur J Pharmacol; 1999 Feb; 366(2-3):189-201. PubMed ID: 10082200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
